SUrgical versus PERcutaneous Bypass: SUPERB-trial; Heparin-bonded endoluminal versus surgical femoro-popliteal bypass: Study protocol for a randomized controlled trial

Trials

Volumn 12, Issue , 2011, Pages

  Lensvelt, Mare M A ^a   Holewijn, Suzanne ^a   Fritschy, Wilbert M ^b   Wikkeling, Otmar R M ^c   van Walraven, Laurens A ^d   Wallis de Vries, Bas M ^e   Zeebregts, Clark J ^e   Reijnen, Michel M P J ^a  

^a RIJNSTATE HOSPITAL   (Netherlands)

^b ISALA HOSPITAL   (Netherlands)

^c NIJ SMELLINGHE HOSPITAL   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Endoluminal; Femoro popliteal bypass; Peripheral arterial occlusive disease; Stentgraft; Superficial femoral artery

Indexed keywords

HEPARIN; ANTICOAGULANT AGENT; BIOMATERIAL;

ARTICLE; CONTROLLED STUDY; EFFECT SIZE; FEMOROPOPLITEAL BYPASS; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NETHERLANDS; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POWER ANALYSIS; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SUPERFICIAL FEMORAL ARTERY; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL TRANSPLANTATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; ENDOVASCULAR SURGERY; FEMORAL ARTERY; HOSPITALIZATION; INSTRUMENTATION; METHODOLOGY; PATHOPHYSIOLOGY; POPLITEAL ARTERY; PROSTHESIS; STENOSIS, OCCLUSION AND OBSTRUCTION; STENT; TEACHING HOSPITAL; TIME; TREATMENT OUTCOME; VASCULAR PATENCY;

ANTICOAGULANTS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CONSTRICTION, PATHOLOGIC; ENDOVASCULAR PROCEDURES; FEMORAL ARTERY; HEPARIN; HOSPITALS, TEACHING; HUMANS; NETHERLANDS; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSTHESIS DESIGN; QUALITY OF LIFE; QUESTIONNAIRES; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 79960564785     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-178     Document Type: Article

References (16)

1. Klinkert P, Post PN, Breslau PJ, van Bockel JH. Saphenous vein versus PTFE for above-knee femoro-popliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 2004, 27:357-62. 10.1016/j.ejvs.2003.12.027, 15015183.
2. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, Fowkes FG, Gillepsie I, Ruckley CV, Raab G, Storkey H, . BASIL trial participants Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005, 366:1925-34. BASIL trial participants.
3. Ansel GM, Lumsden AB. Evolving modalities for femoro-popliteal interventions. J Endovasc Ther 2009, 16(2 Suppl 2):II82-II97.
4. Gibbs JM, Pena CS, Benenati JF. Treating the diseased superficial femoral artery. Tech Vasc Interv Radiol 2010, 13:37-42. 10.1053/j.tvir.2009.10.005, 20123431.
5. Lin PH, Weakley SM, Kougias P. How to interpret data from the superficial femoral artery stenting trials and registries. Semin Vasc Surg 2010, 23:138-47. 10.1053/j.semvascsurg.2010.05.001, 20826290.
6. Mewissen MW. Primary nitinol stenting for femoro-popliteal disease. J Endovasc Ther 2009, 16(2 Suppl 2):II63-II81.
7. Schillinger M, Minar E. Past, present and future of femoro-popliteal stenting. J Endovasc Ther 2009, 16(Suppl 1):I147-I152.
8. Fritschy WM, Kruse RR, Frakking TG, Van Geloven AA, Blomme AM. Performance of ePTFE-covered endograft in patients with occlusive disease of the superficial femoral artery: a three-year clinical follow-up study. J Cardiovasc Surg (Torino) 2010, 51:783-90.
9. McQuade K, Gable D, Pearl G, Theune B, Black S. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg 2010, 52:584-90. 10.1016/j.jvs.2010.03.071, 20598480.
10. Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg 2007, 45:10-16. 10.1016/j.jvs.2006.08.074, 17126520.
11. McQuade K, Gable D, Hohman S, Pearl G, Theune B. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg 2009, 49:109-15. 10.1016/j.jvs.2008.08.041, 19028055.
12. Lindholt JS, Gottschalksen B, Johannesen N, Dueholm D, Ravn H, Christensen ED, Viddal B, Flørenes T, Pedersen G, Rasmussen M, Carstensen M, Grøndal N, Fasting H. The Scandinavian Propaten(®) Trial - 1-Year Patency of PTFE Vascular Prostheses with Heparin-Bonded Luminal Surfaces Compared to Ordinary Pure PTFE Vascular Prostheses - A Randomised Clinical Controlled Multi-centre Trial. Eur J Vasc Endovasc Surg 2011,
13. Bosiers M, Deloose K, Verbist J, Schroë H, Lauwers G, Lansink W, Peeters P. Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoro-popliteal and femorocrural bypass grafting: 1-year results. J Vasc Surg 2006, 43:313-8. 10.1016/j.jvs.2005.10.037, 16476607.
14. Pulli R, Dorigo W, Castelli P, Dorrucci V, Ferilli F, De Blasis G, Monaca V, Vecchiati E, Pratesi C, . Propaten Italian Registry Group Midterm results from a multicenter registry on the treatment of infrainguinal critical limb ischemia using a heparin-bonded ePTFE graft. J Vasc Surg 2010, 51:1167-77. e1, 10.1016/j.jvs.2009.12.042, 20347549, Propaten Italian Registry Group.
15. Schmieder FA, Comerota AJ. Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies. Am J Cardiol 2001, 28(87):3D-13D.
16. Lepäntalo M, Laurila K, Roth WD, Rossi P, Lavonen J, Mäkinen K, Manninen H, Romsi P, Perälä J, Bergqvist D, . Scandinavian Thrupass Study Group PTFE bypass or thrupass for superficial femoral artery occlusion? A randomised controlled trial. Eur J Vasc Endovasc Surg 2009, 37:578-84. 10.1016/j.ejvs.2009.01.003, 19231250, Scandinavian Thrupass Study Group.